The Histone Demethylase Enzymes KDM3A and KDM4B Co-Operatively Regulate Chromatin Transactions of the Estrogen Receptor in Breast Cancer
Many estrogen receptor (ER)-positive breast cancers develop resistance to endocrine therapy but retain canonical receptor signalling in the presence of selective ER antagonists. Numerous co-regulatory proteins, including enzymes that modulate the chromatin environment, control the transcriptional ac...
Main Authors: | Dominic Jones, Laura Wilson, Huw Thomas, Luke Gaughan, Mark A. Wade |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/8/1122 |
Similar Items
-
Small molecule KDM4s inhibitors as anti-cancer agents
by: Hongzhi Lin, et al.
Published: (2018-01-01) -
Activation of TC10-Like Transcription by Lysine Demethylase KDM4B in Colorectal Cancer Cells
by: Baoyu Chen, et al.
Published: (2021-06-01) -
Role for the Histone Demethylase KDM4B in Rhabdomyosarcoma via CDK6 and CCNA2: Compensation by KDM4A and Apoptotic Response of Targeting Both KDM4B and KDM4A
by: Zoë S. Walters, et al.
Published: (2021-04-01) -
Dissecting the Role of the Histone Demethylase KDM1B in Maintenance of Pluripotency and Differentiation of Human Embryonic Stem Cells
by: Alfarhan, Dalal
Published: (2020) -
Maternal LSD1/KDM1A is an essential regulator of chromatin and transcription landscapes during zygotic genome activation
by: Katia Ancelin, et al.
Published: (2016-02-01)